Five things for pharma marketers to know: Monday, October 17, 2016

1. Doctors Without Borders refused to accept one million free pneumonia vaccines from Pfizer over concerns about restrictions that come with donated vaccines. The nonprofit has been pushing Pfizer to lower the price of the Prevnar 13 vaccine. (Modern Healthcare)

2. Valeant Pharmaceuticals International is raising the prices of its stomach, neurology, and urology drugs by up to 9%, but said it will not raise the cost of its eye and skin drugs this year. However, a Wells Fargo analyst notes that Valent raised the prices of three eye drugs in September. (WSJ)

3. Two urologists helped advocate for using drugs to treat overactive bladder, now a $3 billion market. Both urologists had financial ties to companies that make therapies to treat the condition. (Milwaukee Journal Sentinel)

4. A Wikileaks disclosure shows that in 2008 lawmakers pressured the FDA to provide a Democratic donor with access to Biogen's MS drug Tysabri as an experimental treatment for bone-marrow cancer. (Politico)

5. Most patients do not read cautionary risk information on drug websites — even if they think they do. A study that used an eye-tracking tool found they read little or none of the information. (Stat)